<figure><img src="image_1.png" /></figure>

HAL
open science

# Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance

Jennifer Pasquier, Bella Guerrouahen, Hamda Al Thawadi, Pegah Ghiabi, Mahtab Maleki, Nadine Abu-Kaoud, Arthur Jacob, Massoud Mirshahi, Ludovic Galas, Shahin Rafii, et al.

► To cite this version:

Jennifer Pasquier, Bella Guerrouahen, Hamda Al Thawadi, Pegah Ghiabi, Mahtab Maleki, et al. Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance. Journal of Translational Medicine, 2013, 11, pp.94. 10.1186/1479-5876-11-94. hal-02314804

HAL Id: hal-02314804

https://normandie-univ.hal.science/hal-02314804

Submitted on 18 Jun 2021

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
RESEARCH

Open Access

# Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance

Jennifer Pasquier<fnref n="1" />,<fnref n="2" />, Bella S Guerrouahen<fnref n="1" />,<fnref n="2" />, Hamda Al Thawadi<fnref n="1" />, Pegah Ghiabi<fnref n="1" />, Mahtab Maleki<fnref n="1" />, Nadine Abu-Kaoud<fnref n="1" />, Arthur Jacob<fnref n="1" />, Massoud Mirshahi³, Ludovic Galas⁴, Shahin Rafii<fnref n="2" />, Frank Le Foll⁵ and Arash Rafii<fnref n="1" />,<fnref n="2" />*

**Abstract**

Our vision of cancer has changed during the past decades. Indeed tumors are now perceived as complex entities where tumoral and stromal components interact closely. Among the different elements of tumor stroma the cellular component play a primordial role. Bone Marrow derived mesenchymal cells (MSCs) are attracted to tumor sites and support tumor growth. Endothelial cells (ECs) play a major role in angiogenesis. While the literature documents many aspects of the cross talk between stromal and cancer cells, the role of direct hetero-cellular contact is not clearly established. Recently, Tunneling nanotubes (TnTs) have been shown to support cell-to-cell transfers of plasma membrane components, cytosolic molecules and organelles within cell lines. Herein, we have investigated the formation of heterocellular TnTs between stromal (MSCs and ECs) and cancer cells. We demonstrate that TnTs occur between different cancer cells, stromal cells and cancer-stromal cell lines. We showed that TnTs-like structure occurred in 3D anchorage independent spheroids and also in tumor explant cultures. In our culture condition, TnTs formation occurred after large membrane adhesion. We showed that intercellular transfers of cytoplasmic content occurred similarly between cancer cells and MSCs or ECs, but we highlighted that the exchange of mitochondria occurred preferentially between endothelial cells and cancer cells. We illustrated that the cancer cells acquiring mitochondria displayed chemoresistance. Our results illustrate the perfusion-independent role of the endothelium by showing a direct endothelial to cancer cell mitochondrial exchange associated to phenotypic modulation. This supports another role of the endothelium in the constitution of the metastatic niche.

**Keywords:** Tunneling nanotubes, Intercellular transfer, Endothelial cells, Cancer cells, Chemoresistance

**Background**

Tissues are comprised of different cell types that communicate to maintain homeostasis [1]. While cell number and positional identity of normal tissues are lost in cancers, tumor cells keep many interactions with surrounding non-malignant cells and extra-cellular matrix [2]. Indeed, primary and metastatic tumors contain a variety of stromal cell types such as endothelial cells (ECs), fibroblasts and various bone marrow-derived cells,

including macrophages, mast cells, and mesenchymal stem cells (MSCs) [3]. These various cell types are recruited to the tumor site and through the modulation of different pathways contribute to tumor growth and metastasis [4-10]. The interaction between cancer and stromal cells are primordial for the biology of the tumors. Several lines of evidence have been provided. The cross talk between cancer cells and fibroblasts induces phenotypic modification of the stromal cells toward a Cancer Associated Fibroblasts (CAF) phenotype promoting in return the cancer cells [11]. In the metastatic context bone marrow derived cells can be attracted to the site of metastasis and prepare the metastatic niche [12]. Comforting these findings, Park group has demonstrated that a signature of the stroma can predict outcome in

<footnote>* Correspondence: jat2021@qatar-med.cornell.edu</footnote>

<footnote n="1">¹Stem Cell and Microenvironment Laboratory, Weill Cornell Medical College in Qatar, Education City, Qatar Foundation, Doha PO: 24144, Qatar</footnote>

<footnote n="2">²Department of Genetic Medicine, Weill Cornell Medical College, New York, NY, USA</footnote>

<footnote>Full list of author information is available at the end of the article</footnote>
breast cancer patients [13]. Understanding the mechanisms implicated in the relationship between cancer cells and stromal cells are thus essential to target tumor progression.

Several mechanisms are involved in the cross talk between cancer and stromal cells: (i) cytokine/receptor interaction [8,14] (ii) direct cell contact and material exchange [15-17] (iii) micro-particle mediated cell communication [18]. Recently the role of contact-dependent interactions between cancer and stromal cells has been emphasized. These are mediated by synapses, GAP junction and cell-to-cell communication through tunneling nanotubes (TnTs) [19]. First described in cultured rat pheochromocytoma PC12 cells [20], TnTs have been observed in multiple cell types in vitro [21] and more recently in vivo [22,23]. These thin plasma membrane structures connecting cells allow intercellular transfers of organelles, various plasma membrane components and cytoplasmic molecules [24]; calcium ions, major-histo-compatibility proteins (MHC class I), pathogens, small organelles of the endosomal/lysosomal system, mitochondria and ATP-Binding Cassette transporter (P-glycoprotein) have all been shown to be transferred between different cells by TnTs [19,25-29]. While the importance of TnTs-mediated interaction in vivo is still debated in the literature due to lack of a specific inhibitor to tailor their role, there are now evidences demonstrating the functional role of TnTs-mediated intercellular transfer [30].

Several studies demonstrate the existence of TnTs mediated transfers between cancer cells [31]. Thus presence of TnTs was established using cells derived from patient specimens as well as from established cancer cell lines. Different components are transferred through TnTs. However the role of TnTs in forming direct cytoplasmic connections between cancer and stromal cells and their consequences remains to be established.

In this study, we hypothesized that TnTs could mediate cytoplasmic exchange and phenotype transfer between stromal and cancer cells. In our culture conditions we observed TnTs, established between different cancer cells (breast and ovarian cancer cell lines) and stromal cells (mesenchymal stem cells and endothelial cells). We described spontaneous exchange of cytoplasmic material between ECs or MSCs and multiple cancer cell lines. We showed a preferential transfer of mitochondria from endothelial to cancer cells resulting in acquisition of chemoresistance. Thus, our results raise the possibility of direct intercellular exchange as a modulator of tumor phenotype by the stromal component.

# Experimental procedures

## Cell culture

Ovarian cancer cells lines SKOV3 (HTB-77), OVCAR3 (HTB-161), breast cancer cell lines MDA-MB231 and

MCF7 were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were grown in DMEM high glucose (Hyclone, Thermo Scientific) supplemented with 20% FBS (Hyclone, Thermo Scientific), 1% Penicillin-Streptomycin-Amphotericin B solution (Sigma), 2 mM L-glutamine (Sigma), 1X Non-Essential Amino-Acid (Hyclone, Thermo Scientific).

The E4ORF1⁺ ECs (E4⁺ECs) were generously provided by Shahin Rafii [32]. The cells were grown in M199 (Gibco, Life Technologies) supplemented with 20% FBS, 1% Penicillin-Streptomycin-Amphotericin B solution (Sigma), 4 mM L-glutamine, 50 µg/ml heparin (Sigma) and 30 µg/ml β EC growth factor (βECGF, Upstate Biotechnology, Lake Placid, NY, USA). These cells express green fluorescence protein (GFP).

Mesenchymal stem cells (MSCs) were purchased from Stem Cells, Inc (MSC-001 F, Vancouver, CA) maintained and expanded in culture using MesenCult® MSC Basal Medium completed with Mesenchymal Stem Cell Stimulatory Supplements (Stem Cell Inc, Vancouver, CA). Their ability to differentiate in adipocytes, osteoblasts and chnodrocytes was verified as instructed by the supplier (data not shown). All cultured cells were incubated at 37°C under a water-saturated 95% air-5% CO₂ atmosphere. Shaking cultures were performed similarly using a rocking plates at low speed.

## Sphere formation

Cells were dissociated into single cell suspension by trypsinization and further sieving through 40-um cell strainers and subsequently resuspended in 3D media containing DMEM F-12 supplemented with 2% B27 (Invitrogen), 20 ng/mL VEGF (Peprotech), 20 ng/mL bFGF (Peprotech), and 5 µg/mL insulin (Sigma). The cells were plated at 5000 cells per well of ultralow attachment 24-well plates (Costar, Corning) and were grown in a humidified incubator at 37°C and 5% CO₂. The media was changed every second day. Primary spheres started to form at day 3 and continued to be cultured for up to 5 days.

## Explant culture

Tumor material from patients presenting advanced ovarian carcinoma Stage IIIC were included in this study (IRB Number: #9161/2010, "Isolation and characterization of cancer stem cells"). During debulking surgery metastatic nodules were removed and processed as follows. Upon serial washing with PBS and red blood cell Lysis buffer (eBiosciences, San Diego, USA) nodules were minced and cultured with or without feeders (EC⁺E4) in DMEM high glucose (Hyclone, Thermo Scientific) supplemented with 20% FBS (Hyclone, Thermo Scientific), 1% Penicillin-Streptomycin-Amphotericin B solution
(Sigma), 2 mM L-glutamine (Sigma), 1X Non-Essential
Amino-Acid (Hyclone, Thermo Scientific).

Labeling of cell organelles

To trace intercellular exchange of mitochondria, cells
were separately labeled with MitoTracker DeepRed and
Green (Invitrogen) according to the manufacturer's protocol
[26]. Briefly, cells were resuspended in prewarmed (37°C)
staining solution containing the MitoTracker® probe
(50 nM) for 30 minutes under growth conditions appro-
priate. After staining, cells were washed 3 times in PBS
and resuspended in fresh prewarmed medium. Cells were
plated in mono or co-culture according to the experiment.

Confocal microscopy

Live-cell TnTs imaging using previously published
protocols was performed [20]. Cells were labeled with
1 mg/ml Alexa Fluor® 594 conjugated wheat germ
agglutinin (WGA, Invitrogen SARL, Cergy Pontoise,
France) at 5 µg/ml for 10 minutes at 37°C in the
dark. WGA is a probe for detecting glycoconjugates,
which selectively bind to N-acetylglycosamine and N-
acetylneuraminic acid residues of cell membranes.
Imaging was performed using a Zeiss confocal Laser
Scanning Microscope 710 (Carl Zeiss). Post-acquisition
image analysis was performed with Zeiss LSM Image
Browser Version 4.2.0.121 (Carl Zeiss).

Microparticle purification

MPs from eGFP-E4⁺ECs were isolated as previously
described [16]. Briefly, 48-h-supernatants of 80% serum-
starved confluent tumor or endothelial cells were
collected and sequentially centrifuged (4°C) at 300 g for
10 min, 800 g for 10 min, and at 3000 g for 15 min. MPs
were pelleted at 100,000 g for 1 h, and washed once in
PBS and centrifuged again at 100,000 g for 1 h. The
final pellet containing purified MP was labeled with
MitoTracker DeepRed to assess mitochondria transfer by
microparticles.

Analysis of transfer by flow cytometry

After co-culture, cells were trypsinized, resuspended and
washed with PBS. Fluorescence (FL) was quantified on a
SORP FACSAria2 (BD Biosciences). Data were processed
with FACSDiva 6.3 software (BD Biosciences). Doublets
were excluded by FSC-W x FSC-H and SSC-W x SSC-H
analysis; eGFP fluorescence was acquired with 488 nm
blue laser and 510/50 nm emission, Mitotracker Deep
Red was acquired with 640 nm red laser and 670/14 nm
emission. Figures display the median of fluorescence
intensity (mfi) relative to control. Single stained channels
were used for compensation and fluorophore minus one
(FMO) controls were used for gating. 20,000 events were
acquired per sample.

Cell viability study (MTT assay)

Viability of cells was examined with an MTT assay. 24 hours
after treatment with doxorubicin, 10% of MTT reagent was
added to each well to a final concentration of 500 µg/ml,
and the cells were incubated for 4 hours at 37°C. 100 µl of
DMSO were added to each well. Optical density was read
at 570 nm versus 630 with an EnVision multilabel reader
(PerkinElmer, Massachusetts, USA). 3 triplicates were
performed per condition.

Statistical analysis

All quantitative data are expressed as mean ± standard
error of the mean (SEM). Statistical analysis was performed
using SigmaPlot 11 (Systat Software Inc., Chicago, IL). A
Shapiro-Wilk normality test, with a p = 0.05 rejection
value, was used to test normal distribution of data prior to
further analysis. All pairwise multiple comparisons were
performed by one way ANOVA followed by Holm-Sidak
posthoc tests for data with normal distribution or by
Kruskal-Wallis analysis of variance on ranks followed by
Tukey posthoc tests, in case of failed normality test. Paired
comparisons were performed by Student's t-tests or
by Mann-Whitney rank sum tests in case of unequal
variance or failed normality test. Statistical significance
was accepted for p < 0.05 (*), p < 0.01 (**) or p < 0.001 (***).
All experiments were repeated at least three times.

Results

Homocellular and heterocellular TnTs occur
spontaneously in various cancer cell cultures

Previous studies reporting the occurrence of TnTs
in vitro mainly focus on a specific cell types. Here we
determined the presence of TnTs between various cancer
and stromal cells under the same culture conditions. Four
cancer cell lines were assessed (MCF7 and MDA derived
from breast cancers, and SKOV3 and OVCAR3 derived
from ovarian cancers). Homo-cellular TnTs were observed
in all cancer cell lines studied (Additional file 1: Figure
S1A). Similarly TnTs were also found in non-malignant
E4⁺ECs and MSCs (Additional file 1: Figure S1B-C). To
study the role of TnTs in interactions between stromal
and cancer cells, M-Orange-MSCs and eGFP-E4⁺ECs
were co-cultured with different cancer cells. TnTs were
found connecting cancer cells and M-Orange-MSCs or
eGFP-E4⁺EC (Figure 1A-B).

All observed structures displayed the specific charac-
teristics of TnTs: (i) they had no contact to the substratum
and hover in the extracellular medium (Additional file 1:
Figure S2A to C, Additional file 2: Movie 1) (ii) they
exhibited a typical width of less than 0.5 µm and a
length over several cell diameters (Additional file 1:
Figure S2D-E), (iii) they contained F-actin (Additional
file 1: Figure S2F).
<figure><img src="image_3.png" /><figcaption>**Figure 1** Hetero-cellular Tunneling NanoTubes (TnTs) connect stromal to various tumor cells in culture. **A**, confocal imaging of TnTs in co-culture system. Different tumoral cell lines were co-cultured with eGFP-E4⁺ECs. Before imaging by confocal microscopy, the co-cultures were stained with Alexa Fluor 594 conjugated-wheat germ agglutinin (WGA AF594) to reveal cell membranes. Hetero-cellular TnTs can be observed between eGFP-E4⁺ECs in each of the four cell lines studied (MCF7 top left panel, MDA top right panel, SKOV3 bottom left panel, OVCAR3 bottom right panel). Scale bar: 5 µm. **B**, confocal imaging of TnTs in co-culture system. MDA, OVCAR3, SKOV3 or MCF7 cells were stained with CellTracker Green, mixed 1/1 with, M-orange-stained Mesenchymal Stem Cells (MSCs) and plated on glass coverslips for subsequent co-cultures. Before imaging, membranes of the co-cultured cells were stained with WGA AF594. Representative images of hetero-cellular TnTs connecting MDA, OVCAR3, SKOV3 or MCF7 cells TnTs to MSCs are presented. Scale bar: 10 µm. **C**, Phase contrast imaging of ovarian cancer explant. Explants of metastatic ovarian cancer nodules were cultured during ten days in Petri dishes (top left panel). Cells spreading from 3D explants (bottom left panel). TnTs-like structures with high length-to-diameter ratios bridged cells (cell 1 to cell 2 in the right panel). **D**, confocal imaging of 3D cultures. Angiospheres containing MDA and eGFP-E4⁺ECs were grown in 3D media for three days and stained with WGA AF594. TnT can be identified between cancer cells in fluorescence (left panel) and in transmission (right panel) in distinct sphere formations. Scale bar: 10 µm. **E**, confocal imaging of 3D cultures. Angiospheres containing SKOV3 and eGFP-E4⁺ECs were grown in 3D media for three days and stained with WGA AF594. TnT connecting cancer cells and eGFP-E4⁺ECs can be observed. Z-X reconstitution shows TnT typical no attachment to the substrate. Scale bar: 10 µm.</figcaption></figure>

We then studied explants from ovarian cancer metastatic nodules to test whether TNTs could occur in a tumor context. We cultured these in a 3D setting and were able to visualize TnTs-like structures at the periphery of the explants (Figure 1C and Additional file 1: Figure S3A). Recently there has been an emphasis on other cell culture

conditions such as spheroid formation assay. These are performed in low-adherent culture plates and consist in the formation of floating cellular aggregates that evolving in cell spheroids. We therefore assessed the occurrence of TnTs in a 3D anchorage independent spheroid co-culture system. Confocal microscopy
<figure><img src="image_4.png" /></figure>

**Figure 2** Time-lapse studies of TnTs formation. **A**, detailed frames extracted from time-lapse recording of the movie 2. This event happened at 43 seconds in the left corner of movie 2. Duration was reported, 38 min 42 second in total. This set of pictures allows us to see formation of a TnT by membrane projection between MCF-7 and MSCs co-cultured for 24 hours. Scale bar: 10 µm. **B-C**, detailed frames extracted from time-lapse recording of the movie 2. This event happened at 1 min 10 seconds in the left top corner (B) and at 1 min 12 seconds on the right top corner (C). Duration was reported, 49 min 32 seconds (B) and 2 hours 42 min (C). Serial images showing the formation of a nanotube following large membrane adhesion between MCF-7 and MSCs Scale bar: 20 µm. **D**, Detailed frames extracted from time-lapse recording of the movie 5. MCF-7 and eGFP-E4⁺ECs were co-cultured and stained using WGA AF594 to reveal cell membranes. Separated cells migrated toward each other. After the contact lasting the two cells formed nanotubes (arrows) elongating as the cells separated further. Scale bar: 10 µm.
imaging of three days-old mixed spheres (stromal-cancer
cells) displayed TnTs between: (i) cancer cells, (ii) cancer
and stromal cells (Figure 1D and E and Additional file 1:
Figure S3B and C).

Formation of TnTs

Several models have been proposed for the formation
of TnTs, mainly describing the connection between
projections of two cell membranes [30,33]. We observed,
in our culture conditions, such projections of TnTs
between two cells (Figure 2A and Additional file 3:
Movie 2). However, using time-lapse studies, we mainly
observed the following succession of events: cell
migration, large intercellular adhesion, cell separation,
occurrence and/or persistence of TnTs, disruption of
TnTs as the cells separated further (Figure 2B-D and
Additional file 3: Movies 2, Additional file 4: Movie 3,
Additional file 5: Movie 4 and Additional file 6:
Movie 5). This emphasizes the role of large membrane
adhesions before the formation of TnTs.

TnTs mediate preferential transfer of cytoplasmic
components from stromal cells to cancer cells

We used co-culture experiments to investigate a potential exchange of cytosolic content through TnTs. In many instances, we observed TnT-mediated transfer of GFP or M-Orange between cancer and stromal cells. Then, our time-lapse studies confirmed specific movement of dyes along a nanotube suggesting cytoplasmic components transfer from stromal to cancer cells (Figure 3A-B, Additional file 7: Movie 6 and Additional file 8: Movie 7). During phase contrast microscopy analysis, punctual densities were also observed, potentially corresponding to subcellular organelles (Figure 3C-D, Additional file 3: Movie 2). Nanotube mediates transfer of mitochondria between endothelial and endothelial progenitor have been previously described [34]. Therefore, we subsequently investigated the transfer of eGFP-E4⁺ECs mitochondria to cancer cells using the organelle-specific dye Mitotracker. Stained mitochondria could be visualized in the TnTs connecting eGFP-E4⁺ECs to various cancer cells (Figure 4A). Confocal time-lapse imaging demonstrated transfer of

<figure><img src="image_5.png" /></figure>
<figure><img src="image_6.png" /><figcaption>**Figure 4** Transfer of Mitochondria between eGFP-E4⁺ECs and cancer cells. A, confocal images of mitochondria transfer through TnTs. eGFP-E4⁺ECs were stained with MitoTracker Deep-Red to follow their mitochondria. Subsequently, they were co-cultured with cancer cells. Prior to confocal imaging, co-cultures were stained with WGA AF594 to reveal cell membranes. We identified transfer of mitochondria through TnTs from eGFP-E4⁺ECs to cancer cells (MCF7 right panel, MDA left top panel, OVCAR3 and SKOV3 left bottom panels). MitoTracker staining could also be observed in cancer cells cytoplasm. Scale bar: 10 µm. B, detailed frames extracted from movie 8, WGA staining shows the presence of a TnT (left panel), Mitotracker stained material transfer can be observed within the TnT (right panel) C, phase contrast imaging of ovarian cancer explant on eGFP-E4⁺ECs layer. eGFP-E4⁺ECs were stained with MitoTracker Deep-Red. Tumor explants were cultured on a feeder of eGFP-E4⁺ECs stained with Mitotracker (Let panel, scale bar: 500 µm). Confocal imaging were performed after 48 hours of culture. Mitochondria from eGFP-E4⁺ECs were observed within the tumor explant (Middle and right panel, scale bar: 100 µm).</figcaption></figure>

mitochondria stained by Mitotracker (Figure 4B and Additional file 9: Movie 8). We also investigated the transfer of eGFP-E4⁺ECs mitochondria to tumor explants. Indeed, we cultured ovarian cancer tumor explants on eGFP-E4⁺ECs feeder stained with Mitotracker-Red.

After 48 h of culture, tumor explants were removed and confocal analysis showed uptake of eGFP-E4⁺ECs mitochondria (Figure 4C).

To investigate whether organelle transfer displayed cell specificity MCF7 and eGFP-E4⁺ECs or M-Orange-MSCs
A

<figure><img src="image_7.png" /></figure>

B

<figure><img src="image_8.png" /></figure>

<figure><img src="image_9.png" /></figure>

C

<figure><img src="image_10.png" /></figure>

<figure><img src="image_11.png" /></figure>

<figure><img src="image_12.png" /></figure>

<figure><img src="image_13.png" /></figure>

WGA AF594

Mitotracker green (MSC)

WGA AF594

Mitotracker green (MSC)

D

<figure><img src="image_14.png" /></figure>

E

<figure><img src="image_15.png" /></figure>

**Figure 5** Preferential exchange of mitochondria from eGFP-E4⁺ECs to MCF-7. A, confocal imaging of co-cultures between MCF7 and eGFP-E4⁺ECs. Prior to co-culture, eGFP-E4⁺ECs were tagged with MitoTracker Deep Red. After 48 hours, co-cultures were stained with WGA AF594 to reveal cell membrane. eGFP-E4⁺ECs mitochondria could be detected in MCF7 (dotted squares). Scale bar: 20 µm. B, Similar experiments were performed with M-orange-MSCs. No exchange was detected at ratio 1/1. Scale bar: 20 µm. C, Tri-culture of MCF7, MSCs (stained with MitoTracker Green) and non-GFP E4⁺ECs (stained with MitoTracker Red) were performed. After 48 hours, cultures were stained with WGA-AF594. E4⁺ECs mitochondria (blue) were detected in MCF7 and MSCs, while MSCs mitochondria (green) remained restricted to MSCs in this set-up. Scale bar: 20 µm. D, Flow cytometry plot of different ratio of co-culture of eGFP-E4⁺ECs/MCF7. Prior to co-culture eGFP-E4⁺ECs were stained with MitoTracker DeepRed. The number of MCF7 up-taking mitochondria from eGFP-E4⁺ECs increased in relation to the number of eGFP-E4⁺ECs. E, graphical representations of the flow cytometry findings.
<figure><img src="image_16.png" /><figcaption>**Figure 6** Transfer of mitochondria from eGFP-E4⁺ECs to MCF7 confers chemoresistance. A, Flow Cytometry Scatter plot showing the gating strategy for definition of the different cell-populations subjected to cell sorting. B, Confocal imaging post-sorting. Mt⁺MCF7 displayed Mitotracker staining (top left panel) and GFP⁺MCF7, GFP staining (top right panel) however Mt⁺MCF7 did not display Mitotracker nor GFP staining (bottom panel). Scale bar: 10 µm. C, MTT assay after doxorubicine treatment was performed on sorted cells. Mt⁺MCF7 population (red) displayed significantly increased chemoresistance compared to other control populations. However compared to controls, Mt⁺MCF7 (black) or GFP⁺MCF7 (green) displayed also chemoresistance (10 µM doxorubicine). (p < 0.05 (*), p < 0.01 (**) or p < 0.001 (***)). D, Cell viability was assessed for Mt⁺MCF7, Mt⁺MCF7 and control MCF7 treated by 10 µM doxorubicine using Live/Dead Invitrogen kit (calcein AM and ethidium homodimer-1). Mt⁺MCF7 displayed chemoresistance. Experiments were performed in triplicate.</figcaption></figure>
co-cultures were established and mitochondria transfer
from stromal cells was monitored. TnTs seemed similarly
distributed among cell types. However, at a ratio of 1
MCF7 /1 stromal cell, only endothelial cells were able
to transfer mitochondria to MCF7s (Figure 5A-B).
MSCs mitochondria transfer to cancer cells could only
be visualized using an increased ratio (1/10) of MCF7/
MSCs (Additional file 1: Figure S4). We then established
a tri-culture system (MCF7, MSCs and E4⁺ECs). TnTs
were observed between all different cell types, however,
in this setting, MCF7 only acquired E4⁺ECs mitochondria
(Figure 5C). We could also detect uptake of E4⁺ECs
mitochondria by M-Orange-MSCs. Our data provided
evidence for a preferential transfer of mitochondria from
endothelial cells under our culture conditions.

One of the most common criticisms of such experiment
is the ability of the dyes to diffuse. Several findings argued
against such bias. The presence of MCF7 cells with
different level of Mitotracker after 48 hours of co-culture
argued against passive dye transfer. In our tri-culture
set-up, the preferential transfer ruled out the possibility
of passive diffusion. Indeed it is quite unlikely that dyes
would only leak from one cell type. Switching dyes used
between E4⁺ECs and MSCs did not modify these findings
(data not shown). Flow cytometry evaluation of mitochon-
dria uptake at different ratio of eGFP-E4⁺ECs/MCF7
ranging from 1/1 to 1/10 demonstrated that exchange of
mitochondria was related to the number of stromal cells
(Figure 5D-E).

Among other mechanisms involved in the cross-talk
between cancer et stromal cells, microparticles (MPs)
have been involved in the transfer of organelle [35]. We
investigated the implication of MPs in the transfer
of mitochondria between endothelial and cancer cells.
We stained MPs extracted from eGFP-E4⁺ECs using
Mitotracker. While cancer cells were able to uptake
endothelial MPs, the uptake of mitochondria by MCF7
through MPs was negligible (Additional file 1: Figure
S5A-B). Similar results were obtained if endothelial cells
were stained before MPs isolation. This indicated that
mitochondria transfer from eGFP-E4⁺ECs under our cell
culture conditions did not occur through microparticles.
We also used a transwell experiment setting to confirm the
role of direct cell contact in the transfer of mitochondria.
Confocal and flow cytometry analysis could not detect any
Mitotracker-Red uptake in the transwell experiments
(Additional file 1: Figure S6A-B). In order to rule out the
possibility that diffusing Mitotracker into the medium
could be adsorbed by the filter of the transwell chambers,
we seeded MCF7 on the bottom or the top of the
transwell chamber and mitotracker on the other side. Flow
cytometry showed constant staining of MCF7 suggesting
that passive diffusion could occur through the membrane
(Additional file 1: Figure S6C). Finally shaking cultures

that do not allow the formation of TnTs were performed
[36]. Under these conditions no Mitochondria transfer
was observed compare to controls (Additional file 1:
Figure S7). These experiments excluded the possibility of
massive dye transfer and strongly suggested that TnTs
participated to mitochondria transfer.

Acquisition of mitochondria leads to the emergence of a
chemoresistant phenotype

Mitochondria transfer between two cells have been
associated to phenotypic modification [37], however a
direct functional benefit of TnT mediated material
exchange has not yet been demonstrated in the cancer
setting. We hypothesized that MCF7 acquiring endothelial
mitochondria would display greater chemoresistance.
We previously described TnT mediated transfer of
P-glycoprotein from resistant to sensitive cells [29]. We
first verified that both eGFP-E4⁺ECs and MCF7 did not
express ABCB1 (Data not shown).

To assess functional gain, fluorescence minus one
was used to set up the cell-sorting gate as stringent as pos-
sible (Figure 6A). Cells having acquired eGFP-E4⁺ECs
mitochondria (Mt⁺MCF7, red) and cells did not acquire
any mitochondria (Mt⁻MCF7, black) were sorted. Mt⁻
MCF7 population allowed us to control for other factors
such as endothelial secreted factors or direct cell to
cell contact without mitochondria transfer. We finally
sorted cells having only acquired cytoplasmic (excluding
mitochondria) content represented by the GFP⁺MCF7
population (green). We controlled the purity of our cell
sorting by confocal microscopy (Figure 6B) and subjected
the different cell populations to a MTT viability assay in
presence of doxorubicin; MCF7 cells were used as a
control (grey) (Figure 6C). Mt⁻MCF7 and GFP⁺MCF7
displayed chemoresistance (from 1.31 to 1.89 fold
compare to MCF7 control). However MCF7 having ac-
quired eGFP-E4⁺ECs mitochondria (Mt⁺MCF7) displayed
significantly more chemoresistance compared to MCF7
control (1.91 to 3.19 fold, p < 0.05). These results
were confirmed using LiveDead staining (Figure 6D).
These experiments indicated that while co-culture and
transfer of cytoplasmic content induced chemoresistance,
the acquisition of mitochondria significantly increased
chemoresistance of MCF 7 to doxorubicin.

Discussion

In this study, we reported spontaneous TnTs mediated
heterocellular exchange between cancer and stromal
cells. We demonstrated TnTs formation in different
cancer cell types, as well as in two types of stromal cells
highly involved in tumor progression. These findings
support that TnTs formation are ubiquitous. The occur-
rence of TnTs in 3D tumor explants is concordant with
the presence of TnTs in tumors previously described in
human malignant pleural mesothelioma [38]. More interestingly we showed, for the first time TnTs in cancer spheroids, which might be a better model to represent tumor biology and inter-cellular interaction than classical 2D cultures [39].

TnTs between cancer cells and stromal cells had all canonical characteristics previously described [20,24]. Time-lapse studies illustrated that TnTs formation is a common feature and appears to be a dynamic process. We highlighted the primordial role of large cell adhesion domain in the occurrence of TnTs. Thus the formation of TnTs could be consequent to receptor-ligand interaction and exchange of cellular organelles might be dependent of the location and/or nature of initial membrane interaction.

In our different cell culture settings, we demonstrated transfer of cytoplasmic content from stromal to cancer cells. Both MSCs and ECs exchanged cytoplasmic materials with cancer cells without noticeable differences between the cell types. The transfer of cytoplasmic material between similar cell types has been described [30]. Recently some groups have illustrated such phenomena in a heterocellular context [25,37]. We actually observed also transfer of cytoplasmic material from cancer to stromal cells, however the precise significance of this phenomenon is not addressed in this study.

We provided evidence for mitochondrial transfer between stromal and cancer cells through TNTs inducing phenotype modulation. While exchange of cytoplasmic materials appears to happen similarly for MSCs/CCs and E4⁺EC/CCs interactions, we found preferential mitochondria transfer between cancer and endothelial cells in a tri-culture system. We carefully addressed the possibility of leakage and passive diffusion of the dye as follows: (i) we performed cell culture under shaking condition which prevents the formation of TnTs and demonstrated no transfer, (ii) the tri co-culture experiments showed preferential transfer from endothelial toward cancer cells with two different dyes, (iii) in the transwell experiment there was no uptake of mitochondria from the endothelial cells, (iv) Mitotracker used in similar concentration than the one used to stain E4⁺EC was able to cross the membrane of the transwell system and stain cancer cell mitochondria, (v) and finally we were able to follow mitochondria transfer in TnTs by time lapse studies. Using a 3D explant system, we demonstrated that tumor cells of ovarian cancer metastatic nodules could uptake mitochondria from an endothelial cell feeder, suggesting that in dense cellular environments such structures could mediate cell-to-cell communications.

Our analysis of different stromal cell lines pointed out the preferential transfer of mitochondria from endothelial cells compare to MSCs under our culture conditions. This supports the existence of a specific process mediating

such exchanges. The specificity of cargoes transferred has already been illustrated without a precise mechanism, however structural components, specific signaling pathways and/or culture conditions may all play a role [40].

Mitochondria transfer has already been described in different homo- and heterocellular models such as endothelial progenitors and cardiomyocytes [25], astrocytes [41], primary human renal epithelial cells [42], vascular smooth cells and MSCs [37], human retinal pigment epithelial cells [43] and between human malignant pleural mesothelioma cells [38]. Among these studies, only one associated a functional gain via TnT dependent mitochondria exchange. Indeed, Vallabhaneni et al. demonstrated that vascular smooth muscle cells initiate proliferation of mesenchymal stem cells through exchange of mitochondria via TnTs in cocultures [37]. Here, we illustrated the phenotypic advantage of mitochondria uptake. Using a cell sorting strategy controlling for secreted factors, cytoplasmic transfer or cell-to-cell contact, we showed that cells acquiring mitochondria displayed significantly chemoresistance. Functional benefits (survival and resistance to stress) from acquisition of mitochondria have been documented. Spees et al. showed that active transfers of mitochondria could rescue aerobic respiration in cells with dysfunctional mitochondria [44]. They indicated that genetic defects in mitochondria DNA could be rescued by uptake of normally functioning mitochondria from wild-type cells ex vivo. Oliva et al. described the role of increased mitochondrial activity resulting in decreased reactive oxygen species production and in acquisition of chemoresistance in gliomas [45]. Our study is the first reporting chemoresistance linked to mitochondria uptake in a heterocellular context.

Chemotherapy mostly aims at directing specifically cancer cells into apoptosis. Apoptosis is a complex multi-step mechanism. However mitochondrial membrane permeability is a primordial step of apoptosis. Classical anticancer agents such as etoposide, doxorubicin, cisplatin, or paclitaxel (Taxol) cause indirect mitochondrial permeability as they trigger apoptosis by inducing p53 expression; activation of the ceramide/GD3 pathway; by inducing the CD95/CD95L ligand system, affecting Bcl-2-like proteins; and/or by compromising the redox or energy balance [46,47]. Proteins of the Bcl family mediate stabilization of mitochondrial membrane thus preventing apoptosis. Our discovery of mitochondrial transfer from the microenvironment to tumor cells raises questions about tumor cell response to DNA-damaging anticancer drugs.

We acknowledge that other mechanisms might be implicated in conferring chemoresistance such as transfer of other cytoplasmic components (proteins, genetic material), or transcriptome modifications and this will be addressed in further studies.
The presence of TnTs in vivo has been clearly established in the context of developmental biology (between dendritic cell in the mouse cornea [22]; Epithelial Cells in Live Drosophila Wing Imaginal Discs [48]) or neoplasia (mesothelioma tumor biopsies [38]). Their role in different cellular functions ranging from transmission of prions [28,49,50] or virus particles [27,51], electrical coupling [33,52] cell death signaling [53] to chemoresistance acquisition through P-Glycoprotein transfer [29], points out the importance of such physiological process in multicellular organisms.

Many studies point out the importance of cellular contact in mediating tumor phenotype modulation [17,29,54,55]. There are evidences in the literature that relative cellular position in a multicellular context modulate phenotype. Indeed we have previously illustrated that the Hemato-poietic Stem cells reside next to a sinusoidal endothelial niche in the bone marrow [56]. While many local factors (cytokines, membrane bound) certainly play a role, contact mediated phenotypic transfer has a role in specific contexts. The chemoresistance provided by the transfer of mitochondria can lead to the emergence of a residual microscopic disease through dynamic phenotype modula-tion. This emphasize the role of a metastatic niche where the endothelial-tumor cell contact dependant interaction, among other mechanisms, could protect few cancer cells from chemotherapeutic cytotoxicity [57]. Our co-culture experiment and differential sorting strategy revealed the occurrence of phenotypic heterogeneity relying on the interaction between cancer cells and stromal cells. There are many aspects that need to be investigated: understanding the mechanisms underlying (i) the specificity of cell exchange (ii) the constitution of TNTs post-adhesion and (iii) the role of newly acquired mitochondria in the phenotype modification of cancer cells as targeting mitochondria might be a valuable approach in cancer treatments [58].

All together our comprehensive approach points out the importance of TnTs in cross-talk between cancer cells and stromal cells and underlines specificity of such a physiological process. The role of TnTs mediated commu-nication needs to be considered in the context of other cell-to-cell interactions (secreted factors, microparticles, direct cell contact). Tailoring the importance of such mechanisms will lead to a better understanding of tumor dynamics and to design new therapeutic approaches.

## Ethics

IRB was obtained at Hamad Medical Corporation.

## Additional files

**Additional file 1: Figure S1.** Intracellular bridges are present in monocultures of cancer cells, endothelial cells and MSCs. Confocal imaging

of cancer cells (A) or eGFP-E4+ECs (B) or M-orange-MSCs (C) stained with WGA AF594. Homo-cellular TnTs connections can be observed between the different cells used in this study **A**, **Scale bar**: 10 µm. **B**, **Scale bar**: 20 µm. **C**, **Scale bar**: 10 µm. **Figure S2.** TnTs displayed canonical features. Alexa Fluor 594 conjugated-WGA-stained cells were analyzed by live cell confocal microscopy. Observed TNTs were submitted to Z-stack analysis (**A-B**). TNTs were not in contact with the substratum. **C**, Surface rendering (Imaris) illustrating the independency of the TNTs from the substratum (MCF7). **D-E**, TnTs have a diameter smaller than 0.5 µm and a length of up to several cell diameters. **Scale bar**: 20 µm. **F**, Fixed cells were stained with WGA, DAPI and AlexaFluor 647 conjugated-phalloidin. Merged images display co-localization of WGA and TRITC-phalloidin staining, indicating that F-actin is a component of TNTs. **Scale bar**: 10 µm. **Figure S3.** TnTs connect cells in tumor explants and within spheroids. **A**, Ovarian cancer explants were cultured for 10 days. TnT-like structures were detected in the migrating cells of the explant. Cytoplasmic materials could be observed inside the TnTs-like structure (arrows). **Scale bar**: 20 µm. **B-C**, OVCAR3 or MCF7 were grown in spheroid with eGFP-E4+ECs in 3D media on low adherent plates. After 3 days, spheroids were stained with WGA-AF594. TnTs-like structures were detected connecting cells within spheroid structures. (PDF 776 kb) **Scale bar**: 10 µm. **Figure S4.** Mitochondria are transferred through TnTs between MSCs and Cancer cells. **A-C**, Co-culture of M-Orange-MSCs stained with MitoTracker DeepRed and MCF7 at a ratio of 10/1 were performed. Transfer of mitochondria between MSCs and cancer cells could be observed. **Scale bar**: 20 µm. **C**, Cancer Cells with different amount of mitochondria uptake could be observed suggesting active dye transfer. **Scale bar**: 20 µm. **Figure S5.** Microparticles do not mediate mitochondria transfer. Microparticles were extracted from eGFP-E4+ECs and stained with WGA AF594 (A) or MitoTracker Red (B). MCF7 were incubated with the stained microparticles for 24 hours. MCF7 were able to uptake microparticles from eGFP-E4+ECs (B) there was, however, negligible microparticle-mediated passage of mitochondria from eGFP-E4+ECs to MCF7. **Scale bar**: 10 µm. **Figure S6.** Transwell experiments. **A-B**, eGFP-E4+ECs were stained with MitoTracker DeepRed. MCF7 and stained eGFP-E4+ECs were co-incubated in a transwell system. No mitochondria exchange could be detected neither by confocal microscopy (A) nor flow cytometry (B). **Scale bar**: 20 µm. **C**, MCF7 cells were stained by MitoTracker DeepRed through a transwell membrane compare to controls (middle plot: MCF7 plated on the upper side of the transwell, right plot: at the bottom of the membrane). Transwell experiment demonstrating the ability of the Mitotracker dye to stain the MCF7 cells through the transwell system in different settings. **Figure S7.** Shaking culture abrogates the transfer of mitochondria from Endothelial to cancer cells. MCF7 (grey) were co-culture in normal or shaking conditions with eGFP-E4 + ECs (black) stained with Mitotracker DeepRed. While there was a gain of Mitotracker by MCF7 in control set-up (red) no transfer could be observed during shaking (dash red).

**Additional file 2: Movie 1.** Surface rendering of MCF7 cells interconnected by TnTs. Surface rendering of Z-stack confocal imaging of MCF7 with IMARIS software.

**Additional file 3: Movie 2.** TnTs appear spontaneously in co-culture between MCF7 and MSC. 6 hours after plating, co-culture of MCF7 and MSCs were imaged by time-lapse microscopy. The movie sequence was acquired during 24 hours.

**Additional file 4: Movie 3.** Formation of TnTs after large membrane adhesion between ovarian cancer cells. SKOV3 cells were analyzed by confocal microscopy time-lapse imaging. Cells were stained with WGA-AF594 to reveal the membrane (red). The movie sequence represents 1 hour of acquisition. Formation of TnTs after large membrane adhesion are observed.

**Additional file 5: Movie 4.** Formation of TnTs after large membrane interaction between eGFP-E4 + ECs and breast cancer cells. Co-culture of MDA and eGFP-E4+ECs (green) cells was stained with WGA-AF594 to reveal the membrane (red). Stained co-culture was analyzed by confocal microscopy time-lapse imaging. The movie sequence represents 1 hour of acquisition.

**Additional file 6: Movie 5.** Formation of TnTs after membrane interaction between eGFP-E4 + ECs. eGFP-E4+ECs cells (green) were stained with WGA-AF594 to reveal the membrane (red) and analyzed by confocal microscopy time-lapse imaging. The movie sequence represents 40 minutes of acquisition.
**Additional file 7: Movie 6.** TnT-mediated cytoplasmic components transfer from eGFP-E4 + ECs to ovarian cancer cells. Co-culture of eGFP-E4 + ECs (green) and OVCAR3 were stained with WGA AF594 (red) to reveal the membrane and analyzed by confocal microscopy time-lapse imaging. TnT-mediated transfer of WGA stained cytoplasmic content was observed (arrow). The movie sequence represents 1 hour of acquisition.

**Additional file 8: Movie 7.** GFP transfer from eGFP-E4 + ECs to MCF7 through TnTs. Co-culture of eGFP-E4 + ECs (green) and MCF7 were stained with WGA AF594 (red) to reveal the membrane and analyzed by confocal microscopy time-lapse imaging. GFP transfer through TnTs was visualized (arrow). The movie sequence represents 35 minutes of acquisition.

**Additional file 9: Movie 8.** Time-lapse imaging of Mitochondria transfer through TnTs. eGFP-E4 + ECs were stained with Mitotracker DeepRed prior to the co-culture (green). Co-culture of eGFP-E4 + ECs and MCF7 was stained with WGA AF594 to reveal the membrane (red). Co-culture was analyzed by confocal microscopy time-lapse imaging. Movie is showing the mitochondria staining (green) and the WGA staining (red) in the same time. Time-lapse imaging shows transfer of mitochondria among cytoplasmic content through a TnT. The movie sequence represents 2 hours of acquisition.

## Competing interests

The authors declare that they have no competing interests.

## Authors' contributions

Conception and design: JP and AR. Acquisition of data: JP, HAT, PG, MM, NAK and AJ. Analysis and interpretation of the data: JP, MM, LG, FLF and AR. Manuscript preparation: JP and AR wrote the manuscript. Manuscript reviewing: JP, BSG, SR, FLF and AR. All authors read and approved the final manuscript.

## Acknowledgements

This publication was made possible by grants from the Qatar National Research Fund under its National Priorities Research Program award number NPRP 09-1174-3-291 and NPRP 4-640-1-096. Its contents are solely the responsibility of the authors and do not necessarily represent the views of the Qatar National Research Fund. We thank Johannes Graumann for critical reading of this paper and suggestions. We would like to acknowledge Andrew Bliszczyczyk for editorial assistance. We would like to thank Huda Ali Ahmadi for her help in video organization.

## Author details

Received: 5 February 2013 Accepted: 27 March 2013

Published: 10 April 2013

## References

1. Joyce JA, Pollard JW: Microenvironmental regulation of metastasis. *Nat Rev Cancer* 2009, 9:239-252.

2. Udagawa T, Wood M: Tumor-stromal cell interactions and opportunities for therapeutic intervention. *Curr Opin Pharmacol* 2010, 10:369-374.

3. Tlsty TD, Coussens LM: Tumor stroma and regulation of cancer development. *Annu Rev Pathol* 2006, 1:119-150.

4. Coffelt SB, Marini FC, Watson K, Zwezdaryk KJ, Dembinski JL, LaMarca HL, Tomchuck SL, Honer zu Bentrup K, Danka ES, Henkle SL, Scandurro AB: The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. *Proc Natl Acad Sci U S A* 2009, 106:3806-3811.

5. Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, Marini F: Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. *PLoS One* 2009, 4:e4992.

6. Martinet L, Poupot R, Mirshahi P, Rafii A, Fournie JJ, Mirshahi M, Poupot M: *Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses. Int J Cancer* 2010, 126:2143-2152.

7. Pasquet M, Golzio M, Mery E, Rafii A, Benabbou N, Mirshahi P, Hennebelle I, Bourin P, Allal B, Teissie J, et al: *Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Int J Cancer* 2010, 126:2090-2101.

8. Lis R, Touboul C, Mirshahi P, Ali F, Mathew S, Nolan DJ, Maleki M, Abdalla SA, Raynaud CM, Querleu D, et al: Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12. *Int J Cancer* 2011, 128:715-725.

9. St Hill CA: Interactions between endothelial selectins and cancer cells regulate metastasis. *Front Biosci* 2012, 17:3233-3251.

10. Mierke CT: Role of the endothelium during tumor cell metastasis: is the endothelium a barrier or a promoter for cell invasion and metastasis? *J Biophys* 2008, 2008:183516.

11. Cirri P, Chiarugi P: Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. *Cancer Metastasis Rev* 2012, 31:195-208.

12. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, et al: VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. *Nature* 2005, 438:820-827.

13. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, et al: Stromal gene expression predicts clinical outcome in breast cancer. *Nat Med* 2008, 14:518-527.

14. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. *Nature* 2007, 449:557-563.

15. Pasquier J, Galas L, Riba RD, Lecomte C, Rioult D, Bultelle F, Magal P, Webb G, Le Foll F: Different modalities of intercellular membrane exchanges mediate cell-to-cell p-glycoprotein transfers in MCF-7 breast cancer cells. *J Biol Chem* 2012, 287:7374-7387.

16. Pasquier J, Magal P, Boulange-Lecomte C, Webb G, Le Foll F: Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model. *Biol Direct* 2011, 6:5.

17. Rafii A, Mirshahi P, Poupot M, Faussat AM, Simon A, Ducros E, Mery E, Couderc B, Lis R, Capdet J, et al: Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours. *PLoS One* 2008, 3:e3894.

18. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garcia-Santos G, Ghajar C, et al: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. *Nat Med* 2012, 18:883-891.

19. Gerdes HH, Bukoreshtliev NV, Barroso JF: Tunneling nanotubes: a new route for the exchange of components between animal cells. *FEBS Lett* 2007, 581:2194-2201.

20. Rustom A, Saffrich R, Markovic I, Walther P, Gerdes HH: Nanotubular highways for intercellular organelle transport. *Science* 2004, 303:1007-1010.

21. Gerdes HH, Carvalho RN: Intercellular transfer mediated by tunneling nanotubes. *Curr Opin Cell Biol* 2008, 20:470-475.

22. Chinnery HR, Pearlman E, McMenamin PG: Cutting edge: Membrane nanotubes in vivo: a feature of MHC class II + cells in the mouse cornea. *J Immunol* 2008, 180:5779-5783.

23. Pyrgaki C, Trainor P, Hadjantonakis AK, Niswander L: Dynamic imaging of mammalian neural tube closure. *Dev Biol* 2010, 344:941-947.

24. Gurke S, Barroso JF, Gerdes HH: The art of cellular communication: tunneling nanotubes bridge the divide. *Histochem Cell Biol* 2008, 129:539-550.

25. Koyanagi M, Brandes RP, Haendeler J, Zeiher AM, Dimmeler S: Cell-to-cell connection of endothelial progenitor cells with cardiac myocytes by nanotubes: a novel mechanism for cell fate changes? *Circ Res* 2005, 96:1039-1041.

26. Gurke S, Barroso JF, Hodneland E, Bukoreshtliev NV, Schlicker O, Gerdes HH: Tunneling nanotube (TNT)-like structures facilitate a constitutive, actomyosin-dependent exchange of endocytic organelles between normal rat kidney cells. *Exp Cell Res* 2008, 314:3669-3683.

27. Eugenin EA, Gaskill PJ, Berman JW: Tunneling nanotubes (TNT) are induced by HIV-infection of macrophages: a potential mechanism for intercellular HIV trafficking. *Cell Immunol* 2009, 254:142-148.

<footnote n="1">¹Stem Cell and Microenvironment Laboratory, Weill Cornell Medical College in Qatar, Education City, Qatar Foundation, Doha PO: 24144, Qatar.</footnote>

<footnote n="2">²Department of Genetic Medicine, Weill Cornell Medical College, New York, NY, USA. ³UMRS 872 INSERM, Université Pierre et Marie Curie-Paris 6 and Université Paris Descartes, Equipe 18, Centre de Recherche des Cordeliers, 15 rue de l'École de Médecine, Paris Cedex 06 75270, France. ⁴Primacén Cellular Imaging Platform, University of Rouen, Mont-Saint-Aignan 76821, France.</footnote>

<footnote n="5">⁵Laboratory of Ecotoxicology, University of Le Havre, Le Havre 76058, France.</footnote>
28. Gerdes HH: Prions tunnel between cells. *Nat Cell Biol* 2009, **11**:235-236.

29. Pasquier J, Galas L, Boulange-Lecomte C, Rioult D, Bultelle F, Magal P, Webb G, Le Foll R: Different Modalities of Intercellular Membrane Exchanges Mediate Cell-to-Cell P-Glycoprotein Transfers in Mcf-7 Breast Cancer Cells. *J Biol Chem* 2012, **287**(10):7374-7387. doi:10.1074/jbc.M111.312157.

30. Abounit S, Zurzolo C: Wiring through tunneling nanotubes-from electrical signals to organelle transfer. *J Cell Sci* 2012, **125**:1089-1098.

31. Lou E, Fujisawa S, Barlas A, Romin Y, Manova-Todorova K, Moore MA, Subramanian S: Tunneling Nanotubes: A new paradigm for studying intercellular communication and therapeutics in cancer. *Commun Integr Biol* 2012, **5**:399-403.

32. Seandel M, Butler JM, Kobayashi H, Hooper AT, White IA, Zhang F, Vertes EL, Kobayashi M, Zhang Y, Shmelkov SV, et al: Generation of a functional and durable vascular niche by the adenoviral E4ORF1 gene. *Proc Natl Acad Sci U S A* 2008, **105**:19288-19293.

33. Wang X, Gerdes HH: Long-distance electrical coupling via tunneling nanotubes. *Biochim Biophys Acta* 1818, 2012:2082-2086.

34. Yasuda K, Khandare A, Burianovskyy L, Maruyama S, Zhang F, Nasjletti A, Goligorsky MS: Tunneling nanotubes mediate rescue of prematurely senescent endothelial cells by endothelial progenitors: exchange of lysosomal pool. *Aging* 2011, **3**:597-608.

35. Cocucci E, Racchetti G, Meldolesi J: Shedding microvesicles: artefacts no more. *Trends Cell Biol* 2009, **19**:43-51.

36. Sourisseau M, Sol-Foulon N, Porrot F, Blanchet F, Schwartz O: Inefficient human immunodeficiency virus replication in mobile lymphocytes. *J Virol* 2007, **81**:1000-1012.

37. Vallabhaneni K, Haller H, Dumler I: Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondria transfer via tunneling nanotubes. *Stem Cells Dev* 2012, **21**(17):3104-3113.
doi:10.1089/scd.2011.0691. Epub 2012 Jul 13.

38. Lou E, Fujisawa S, Morozov A, Barlas A, Romin Y, Dogan Y, Gholami S, Moreira AL, Manova-Todorova K, Moore MA: Tunneling nanotubes provide a unique conduit for intercellular transfer of cellular contents in human malignant pleural mesothelioma. *PLoS One* 2012, **7**:e33093.

39. Santini MT, Rainaldi G: Three-dimensional spheroid model in tumor biology. *Pathobiology* 1999, **67**:148-157.

40. Marzo L, Gousset K, Zurzolo C: Multifaceted roles of tunneling nanotubes in intercellular communication. *Front Physiol* 2012, **3**:72.

41. Wang Y, Cui J, Sun X, Zhang Y: Tunneling-nanotube development in astrocytes depends on p53 activation. *Cell Death Differ* 2011, **18**:732-742.

42. Domhan S, Ma L, Tai A, Anaya Z, Beheshti A, Zeier M, Hlatky L, Abdollahi A: Intercellular communication by exchange of cytoplasmic material via tunneling nano-tube like structures in primary human renal epithelial cells. *PLoS One* 2011, **6**:e21283.

43. Wittig D, Wang X, Walter C, Gerdes HH, Funk RH, Roehlecke C: Multi-level communication of human retinal pigment epithelial cells via tunneling nanotubes. *PLoS One* 2012, **7**:e33195.

44. Spees JL, Olson SD, Whitney MJ, Prockop DJ: Mitochondrial transfer between cells can rescue aerobic respiration. *Proc Natl Acad Sci U S A* 2006, **103**:1283-1288.

45. Oliva CR, Moellering DR, Gillespie GY, Griguer CE: Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production. *PLoS One* 2011, **6**:e24665.

46. Costantini P, Jacotot E, Decaudin D, Kroemer G: Mitochondrion as a novel target of anticancer chemotherapy. *J Natl Cancer Inst* 2000, **92**:1042-1053.

47. Galluzzi L, Larochette N, Zamzami N, Kroemer G: Mitochondria as therapeutic targets for cancer chemotherapy. *Oncogene* 2006, **25**:4812-4830.

48. Demontis F, Dahmann C: Apical and lateral cell protrusions interconnect epithelial cells in live Drosophila wing imaginal discs. *Dev Dyn* 2007, **236**:3408-3418.

49. Gousset K, Schiff E, Langevin C, Marijanovic Z, Caputo A, Browman DT, Chenouard N, de Chaumont F, Martino A, Enninga J, et al: Prions hijack tunnelling nanotubes for intercellular spread. *Nat Cell Biol* 2009, **11**:328-336.

50. Gousset K, Zurzolo C: Tunnelling nanotubes: a highway for prion spreading? *Prion* 2009, **3**:94-98.

51. Sowinski S, Jolly C, Beringhausen O, Purbhoo MA, Chauveau A, Kohler K, Oddos S, Eissmann P, Brodsky FM, Hopkins C, et al: Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. *Nat Cell Biol* 2008, **10**:211-219.

52. Wang X, Veruki ML, Bukoreshtliev NV, Hartveit E, Gerdes HH: Animal cells connected by nanotubes can be electrically coupled through interposed gap-junction channels. *Proc Natl Acad Sci U S A* 2010, **107**:17194-17199.

53. Arkwright PD, Luchetti F, Tour J, Roberts C, Ayub R, Morales AP, Rodriguez JJ, Gilmore A, Canonico B, Papa S, Esposti MD: Fas stimulation of T lymphocytes promotes rapid intercellular exchange of death signals via membrane nanotubes. *Cell research* 2010, **20**:72-88.

54. Bebawy M, Combes V, Lee E, Jaiswal R, Gong J, Bonhoure A, Grau GE: Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. *Leukemia* 2009, **23**:1643-1649.

55. Levchenko A, Mehta BM, Niu X, Kang G, Villafania L, Way D, Polycarpe D, Sadelin M, Larson SM: Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. *Proc Natl Acad Sci U S A* 2005, **102**:1933-1938.

56. Hooper AT, Butler JM, Nolan DJ, Kranz A, Iida K, Kobayashi M, Kopp HG, Shido K, Petit I, Yanger K, et al: Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. *Cell Stem Cell* 2009, **4**:263-274.

57. Witz IP: Tumor-microenvironment interactions: dangerous liaisons. *Adv Cancer Res* 2008, **100**:203-229.

58. Fulda S, Galluzzi L, Kroemer G: Targeting mitochondria for cancer therapy. *Nature reviews Drug discovery* 2010, **9**:447-464.

doi:10.1186/1479-5876-11-94

Cite this article as: Pasquier et al.: Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance. *Journal of Translational Medicine* 2013 11:94.

Submit your next manuscript to BioMed Central and take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at
www.biomedcentral.com/submit

BioMed Central